Equasens reports a 9% increase in sales to 112.6 million euros for the first half of 2023, with 'growth in all divisions except Fintech, which nevertheless began a more favorable trend in the second quarter'.

The pharmacy IT group highlights the contribution of Ségur du Numérique en Santé, continuing its installations of Ségur-referenced solutions, which represented two million euros at June 30, 2023.

In terms of outlook, Equasens anticipates 'continued growth in the second half of 2023, with the release of new products (mobility, security, SaaS offers, etc.) boosting sales across all sectors'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.